Assessing the Effect of Contraception and the Menstrual Cycle on Pharmacokinetics, Pharmacodynamics, and Vaginal Safety in Tenofovir Vaginal Gel Users
Phase of Trial: Phase I
Latest Information Update: 13 Apr 2015
At a glance
- Drugs Tenofovir (Primary) ; Ethinylestradiol/levonorgestrel; Medroxyprogesterone
- Indications Hepatitis B; HIV infections; Pregnancy
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors CONRAD
- 09 Apr 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 11 Dec 2013 Planned end date changed from 1 Oct 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov record.
- 11 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.